List of insiders holdings for RIGEL PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | MPM BIOEQUITIES MASTER FUND LP MPM BIOEQUITIES GP LP MPM BIOEQUITIES GP LLC MPM BIOEQUITIES FUND GMBH & CO KG EVNIN LUKE GADICKE ANSBERT LIPTAK ROBERT EMSTER KURT VON 10% Owner |
2004-02-23 20:17:11 | 0 4,350,516 |
4,350,516 | Form 4 |
| 2 | EVNIN LUKE GADICKE ANSBERT Former 10% Owner |
2004-09-15 17:53:50 | 0 2,637,124 |
2,637,124 | Form 4 |
| 3 | MPM BIOVENTURES III QP LP MPM BIOVENTURES III LP MPM BIOVENTURES III GMBH & CO MPM BIOVENTURES III PARALLEL FUND MPM ASSET MANAGEMENT INVESTORS 2003 BVIII LLC MPM BIOVENTURES III GP LP MPM BIOVENTURES III LLC GALAKATOS NICHOLAS STEINMETZ MICHAEL WHEELER KURT Former 10% Owner |
2004-09-15 17:55:55 | 0 2,637,124 |
2,637,124 | Form 4 |
| 4 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF INC LAMPERT MARK N BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC 10% Owner |
2014-03-12 17:18:20 | 2,576,707 0 |
2,576,707 | Form 13G |
| 5 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC INVESTMENT 10 LLC BVF INC LAMPERT MARK N 10% Owner |
2014-03-12 17:18:20 | 2,576,707 0 |
2,576,707 | Form 13G |
| 6 | FRAZIER HEALTHCARE IV LP FHM IV LP FHM IV LLC 10% Owner |
2004-02-24 20:33:18 | 1,217,467 6,180 |
1,223,647 | Form 4 |
| 7 | DELEAGE JEAN ALTA PARTNERS ALTA CALIFORNIA PARTNERS LP ALTA EMBARCADERO PARTNERS LLC ALTA CALIFORNIA MANAGEMENT PARTNERS LP GRUENER GARRETT NOHRA GUY P Director |
2004-11-02 15:45:19 | 809,141 0 |
809,141 | Form 13G |
| 8 | Flynn James E DEERFIELD CAPITAL LP Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS LP DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund International LTD DEERFIELD INTERNATIONAL LTD Possible Member of 10% Group 10% Owner |
2014-02-14 15:46:12 | 788,675 0 |
788,675 | Form 13G |
| 9 | GOWER JAMES M CEO & Board Chairman |
2014-03-03 18:47:40 | 250,000 0 |
250,000 | Form 4 |
| 10 | Grossbard Elliott B EVP, CMO |
2016-01-28 18:46:53 | 150,000 0 |
150,000 | Form 4 |
| 11 | MOOS WALTER H Director |
2024-05-29 19:21:08 | 132,222 0 |
132,222 | Form 4 |
| 12 | LAPOINTE ANTHONY GREGG Director |
2024-05-29 19:20:45 | 130,000 0 |
130,000 | Form 4 |
| 13 | Kotzin Brian L. Director |
2024-05-29 19:20:29 | 130,000 0 |
130,000 | Form 4 |
| 14 | Wasman Jane Director |
2024-05-29 19:21:27 | 130,000 0 |
130,000 | Form 4 |
| 15 | HANNAH ALISON L. Director |
2024-05-29 19:20:11 | 111,250 0 |
111,250 | Form 4 |
| 16 | LYONS GARY A Director |
2023-07-12 18:45:31 | 105,000 0 |
105,000 | Form 4 |
| 17 | Ali-Jackson Kamil Director |
2024-05-29 19:19:26 | 98,750 0 |
98,750 | Form 4 |
| 18 | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. |
2022-09-16 16:15:53 | 81,250 0 |
81,250 | Form 4 |
| 19 | Mayer Eldon C. III EVP & Chief Commercial Officer |
2019-11-20 20:15:07 | 75,000 0 |
75,000 | Form 4 |
| 20 | Duliege Anne-Marie EVP & Chief Medical Officer |
2019-03-22 19:19:52 | 75,000 0 |
75,000 | Form 4 |
| 21 | Maynard Ryan D EVP & CFO |
2017-11-07 21:07:01 | 75,000 0 |
75,000 | Form 4 |
| 22 | Dummer Wolfgang EVP & CMO |
2023-02-06 17:40:17 | 72,459 0 |
72,459 | Form 4 |
| 23 | Goodwin Bradford S Director |
2021-05-21 21:09:06 | 65,000 0 |
65,000 | Form 4 |
| 24 | Markel Stacy EVP Human Resources |
2019-03-22 19:26:33 | 62,500 0 |
62,500 | Form 4 |
| 25 | Masuda Esteban Sr. VP Research |
2019-11-20 20:18:03 | 62,500 0 |
62,500 | Form 4 |
| 26 | RODRIGUEZ RAUL R CEO, President |
2025-03-19 20:56:04 | 56,250 0 |
56,250 | Form 4 |
| 27 | Katkin Keith Director |
2021-05-21 20:57:44 | 55,000 0 |
55,000 | Form 4 |
| 28 | PAYAN DONALD G EVP, Pres. Discovery&Research |
2016-09-01 18:18:46 | 0 53,031 |
53,031 | Form 4 |
| 29 | WELCH JAMES H CFO, VP & Secretary |
2006-01-27 17:30:21 | 45,000 0 |
45,000 | Form 4 |
| 30 | Lasaga Joseph Sr.VP Bus.Dev.Alliance Mgmt. |
2019-11-20 20:20:48 | 43,750 0 |
43,750 | Form 4 |
| 31 | RINGROSE PETER S Director |
2018-05-18 21:37:52 | 40,000 0 |
40,000 | Form 4 |
| 32 | SHERWIN STEPHEN A Director |
2016-05-12 19:03:34 | 40,000 0 |
40,000 | Form 4 |
| 33 | ALTA PARTNERS II INC ALTA BIOPHARMA PARTNERS II LP ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC CHAMPSI FARAH MARDUEL ALIX ALTA BIOPHARMA MANAGEMENT II LLC X-ref Alta Partners II 5/20/04 |
2004-08-24 18:18:30 | 0 29,715 |
29,715 | Form 4 |
| 34 | Cabatuan Nelson VP,Finance & Princ.Acctg. Off. |
2020-05-15 20:57:24 | 20,000 0 |
20,000 | Form 4 |
| 35 | Furey Raymond J. EVP, GC, CCO & Corp Sec |
2025-03-19 20:55:51 | 17,225 0 |
17,225 | Form 4 |
| 36 | DELEAGE JEAN Director |
2010-05-28 18:55:18 | 15,000 0 |
15,000 | Form 4 |
| 37 | RENTON HOLLINGS Director |
2013-05-28 19:14:59 | 15,000 0 |
15,000 | Form 4 |
| 38 | Santos David A EVP, Chief Commercial Officer |
2025-03-19 20:56:27 | 14,725 0 |
14,725 | Form 4 |
| 39 | Schorno Dean L EVP & Chief Financial Officer |
2025-03-19 20:56:36 | 13,475 0 |
13,475 | Form 4 |
| 40 | Frohlich Mark W Director |
2025-03-10 17:42:13 | 12,000 0 |
12,000 | Form 4 |
| 41 | SIMON NICHOLAS J III Director |
2005-06-03 15:36:54 | 10,000 0 |
10,000 | Form 4 |
| 42 | COOPER ROBIN D G Sr. V.P. Pharmaceutical Scs. |
2008-02-04 19:49:51 | 10,000 0 |
10,000 | Form 4 |
| 43 | Rojkjaer Lisa EVP, Chief Medical Officer |
2025-03-19 20:56:18 | 9,375 0 |
9,375 | Form 4 |
| 44 | FRAZIER ALAN D Director |
2006-08-08 20:38:40 | 556 0 |
556 | Form 4 |
| 45 | HENNER DENNIS Director |
2005-01-10 16:36:04 | 0 0 |
0 | Form 4 |